(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one(DAH-II) CAS:156732-13-7

DAH-II plays a crucial role in biochemical and pharmaceutical research due to its specific chemical structure and properties. It serves as a key intermediate in the synthesis of bioactive molecules and pharmaceutical agents. The compound's structure includes an amino group and a dibenzylamino group, which are strategically important in medicinal chemistry. Researchers leverage these groups for the development of novel pharmaceuticals targeting various diseases, including cancer and neurological disorders. In drug discovery, DAH-II is used to synthesize analogs and derivatives with potential therapeutic applications. These compounds are designed to enhance biological activity, improve pharmacokinetic profiles, or modulate specific biological pathways. DAH-II and its derivatives are also valuable tools for understanding structure-activity relationships (SAR) in drug design. Furthermore, DAH-II's unique structure allows researchers to explore its potential in biochemical assays and biophysical studies. Its stability and solubility characteristics facilitate its use in studying protein-ligand interactions and biochemical pathways, providing insights into molecular recognition and drug action mechanisms. The compound's (S,Z) configuration is particularly significant in its application to peptide chemistry and drug development. Researchers investigate how this stereochemistry influences biological activity, aiding in the design of more effective therapeutic agents. In summary, DAH-II is a versatile chemical tool in pharmaceutical research, enabling advancements in drug discovery, molecular biology, and therapeutic development. Its unique structural features and chemical properties make it indispensable for studying bioactive compound synthesis, optimizing drug candidates, and unraveling complex biological mechanisms at the molecular level.